(Q34164493)

31 July 2017

1 reference

title

New treatments for viral respiratory tract infections--opportunities and problems (English)

1 reference

31 July 2017

Snell NJ

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of Antimicrobial Chemotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

251-259

1 reference

Herpes simplex virus infection in heart-lung transplant recipients.

31 July 2017

cites work

1 reference

12 December 2020

Influenza virus. Amantadine blocks the channel

1 reference

12 December 2020

Chemotherapeutic control of influenza

1 reference

12 December 2020

Low incidence of rimantadine resistance in field isolates of influenza A viruses

1 reference

12 December 2020

Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation

1 reference

12 December 2020

Treatment of Cytomegaloviral Pneumonia with High-Dose Acyclovir and Human Leukocyte Interferon

1 reference

12 December 2020

A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection

1 reference

12 December 2020

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

12 December 2020

Prevention of respiratory syncytial virus infection with palivizumab

1 reference

12 December 2020

Management of herpes virus infections following transplantation

1 reference

12 December 2020

Influenza virus resistance to neuraminidase inhibitors

1 reference

12 December 2020

Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid

1 reference

12 December 2020

Conventional respiratory viruses recovered from immunocompromised patients: clinical considerations

1 reference

12 December 2020

Deposition and disposition of [11C]zanamivir following administration as an intranasal spray. Evaluation with positron emission tomography

1 reference

12 December 2020

Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report

1 reference

12 December 2020

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

1 reference

12 December 2020

Management strategies for respiratory syncytial virus infections in infants.

1 reference

12 December 2020

Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents

1 reference

12 December 2020

Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview.

1 reference

12 December 2020

A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.

1 reference

12 December 2020

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis

1 reference

12 December 2020

Delivery of peptide and non-peptide drugs through the respiratory tract

1 reference

12 December 2020

Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV.

1 reference

12 December 2020

Epidemiology, pathogenesis, and treatment of the common cold

1 reference

12 December 2020

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

12 December 2020

Antiviral agent blocks breathing of the common cold virus.

1 reference

12 December 2020

Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle

1 reference

12 December 2020

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

1 reference

12 December 2020

Costs and Outcomes of Prolonged Cytomegalovirus Prophylaxis to Cover the Enhanced Immunosuppression Phase Following Lung Transplantation

1 reference

12 December 2020

Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1

1 reference

12 December 2020

Respiratory distress associated with zanamivir

1 reference

12 December 2020

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

1 reference

12 December 2020

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

1 reference

12 December 2020

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

1 reference

12 December 2020

Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation

1 reference

12 December 2020

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease

1 reference

12 December 2020

Hantavirus pulmonary syndrome in the Americas: the early years

1 reference

12 December 2020

HIV infection increases susceptibility to smoking-induced emphysema

1 reference

12 December 2020

Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir

1 reference

12 December 2020

Children with influenza A infection: treatment with rimantadine.

1 reference

12 December 2020

The role of viruses in the pathogenesis of hypersensitivity pneumonitis

1 reference

12 December 2020

Advances in prevention of respiratory syncytial virus infections

1 reference

12 December 2020

Why aren't antivirals effective when administered intranasally?

1 reference

12 December 2020

Molecular basis of drug resistance to new antirhinovirus agents

1 reference

12 December 2020

Latent adenoviral infection in the pathogenesis of chronic airways obstruction

1 reference

12 December 2020

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

1 reference

12 December 2020

A protein-based therapeutic for human cytomegalovirus infection

1 reference

12 December 2020

Respiratory viral infections in immunocompetent and immunocompromised persons

1 reference

12 December 2020

Molecular mechanisms of action of ribavirin

1 reference

12 December 2020

Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial

1 reference

12 December 2020

Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection

1 reference

12 December 2020

1 reference

12 December 2020

Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature

1 reference

12 December 2020

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

1 reference

12 December 2020

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

1 reference

12 December 2020

Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report

1 reference

12 December 2020

Implications of the Relenza ruling

1 reference

12 December 2020

Chemotherapy of respiratory viruses.

1 reference

12 December 2020

Prevention and treatment of influenza in immunocompromised patients

1 reference

12 December 2020

Palivizumab: an overview.

1 reference

12 December 2020

The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance

1 reference

12 December 2020

Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group

1 reference

12 December 2020

Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study

1 reference

12 December 2020

Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a

1 reference

12 December 2020

Viruses and idiopathic pulmonary fibrosis

1 reference

12 December 2020

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

1 reference

12 December 2020

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

12 December 2020

In vivo Selection of an Influenza A2 Strain resistant to Amantadine

1 reference

12 December 2020

Impact of respiratory virus infections on persons with chronic underlying conditions

1 reference

12 December 2020

Resistance to antiviral drugs: the end of innocence.

1 reference

12 December 2020

1 reference

12 December 2020

Respiratory viral infections in adults with and without chronic obstructive pulmonary disease

1 reference

12 December 2020

Prolonged Shedding of Amantadine-Resistant Influenza A Viruses by Immunodeficient Patients: Detection by Polymerase Chain Reaction-Restriction Analysis

1 reference

12 December 2020

1 reference

12 December 2020

Pilot trial of ribavirin for the treatment of laryngeal papillomatosis

1 reference

12 December 2020

Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial

1 reference

12 December 2020

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

12 December 2020

Respiratory syncytial virus infection

1 reference

12 December 2020

The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit

1 reference

12 December 2020

Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.

1 reference

12 December 2020

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

1 reference

12 December 2020

Recurrent respiratory papillomatosis: juvenile versus adult forms

1 reference

12 December 2020

Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro

1 reference

12 December 2020

Identifiers

DOI

10.1093/JAC/47.3.251

1 reference

31 July 2017

1 reference